104 related articles for article (PubMed ID: 7569076)
41. [Combined intraductal and percutaneous radiotherapy of malignant bile duct obstruction with subsequent prosthetic management].
Brambs HJ; Freund U; Bruggmoser G; Wannenmacher M
Onkologie; 1987 Apr; 10(2):84-9. PubMed ID: 3295631
[TBL] [Abstract][Full Text] [Related]
42. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
Leung JT; Kuan R
Australas Radiol; 1997 May; 41(2):151-4. PubMed ID: 9153812
[TBL] [Abstract][Full Text] [Related]
43. Unresectable hilar cholangiocarcinoma: multimodality treatment with percutaneous and intraluminal plus external radiotherapy.
Golfieri R; Giampalma E; Fusco F; Galuppi A; Faccioli L; Galaverni C; Frezza G
J Chemother; 2004 Nov; 16 Suppl 5():55-7. PubMed ID: 15675480
[TBL] [Abstract][Full Text] [Related]
44. [Radiotherapy of malignant obstructive jaundice].
Nilles A; Frommhold H; Bruggmoser G
Chirurg; 1994 Oct; 65(10):832-5. PubMed ID: 7529669
[TBL] [Abstract][Full Text] [Related]
45. [Present status and possibilities of radiotherapy in the interdisciplinary treatment of malignant tumors of the stomach, pancreas and bile ducts. III. Extrahepatic bile ducts and gallbladder].
Köster R; Scherer E
Strahlentherapie; 1984 Jul; 160(7):403-10. PubMed ID: 6431648
[TBL] [Abstract][Full Text] [Related]
46. [Clinical experiences with intraluminal irradiation using 198Au grains in the treatment of bile duct carcinoma].
Hiratsuka J; Kodama A; Imajo Y; Nishishita S; Narihiro N; Nagase N; Numaguchi K; Wada A; Yamamoto M; Oumi T
Gan No Rinsho; 1989 Feb; 35(3):355-9. PubMed ID: 2926983
[TBL] [Abstract][Full Text] [Related]
47. Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma.
Karani J; Fletcher M; Brinkley D; Dawson JL; Williams R; Nunnerley H
Clin Radiol; 1985 Nov; 36(6):603-6. PubMed ID: 2998683
[TBL] [Abstract][Full Text] [Related]
48. Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region.
Dvorák J; Petera J; Papík Z; Melichar B; Vanásek T; Hulek P; Jandík P; Mergancová J; Zoul Z; Vacek Z
Hepatogastroenterology; 2002; 49(46):1045-7. PubMed ID: 12143198
[TBL] [Abstract][Full Text] [Related]
49. Use of vitallium prosthesis to relieve jaundice in patients with obstruction at the bifurcation of the hepatic duct.
Niloff PH; Hinchey EJ
Can J Surg; 1982 Nov; 25(6):701-3. PubMed ID: 6291735
[TBL] [Abstract][Full Text] [Related]
50. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.
Chen Y; Wang XL; Yan ZP; Cheng JM; Wang JH; Gong GQ; Qian S; Luo JJ; Liu QX
World J Gastroenterol; 2004 Dec; 10(23):3506-10. PubMed ID: 15526374
[TBL] [Abstract][Full Text] [Related]
51. Biliary tree malignancies: the University of Minnesota experience.
Lee CK; Barrios BR; Bjarnason H
J Surg Oncol; 1997 Aug; 65(4):298-305. PubMed ID: 9274796
[TBL] [Abstract][Full Text] [Related]
52. Extrahepatic obstructive jaundice due to colorectal cancer.
Sung MW; Bruckner HW; Szabo S; Mitty HA
Am J Gastroenterol; 1988 Mar; 83(3):267-70. PubMed ID: 3278594
[TBL] [Abstract][Full Text] [Related]
53. [265-day survival after percutaneous drainage to correct cholemia caused by an inoperable tumor of the bile ducts].
Skrzelewski S; Dobrowolski J
Wiad Lek; 1985 Feb; 38(3):229-33. PubMed ID: 4002716
[No Abstract] [Full Text] [Related]
54. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma: regarding Montemaggi et al., IJROBP 32:437; 1995.
Mohan DS; Nori D
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):773-4. PubMed ID: 7558972
[No Abstract] [Full Text] [Related]
55. [Guideline in (suspected) malignant obstruction of the proximal bile ducts].
van Leeuwen DJ; Verbeek PC; Smits NJ; Gonzalez Gonzalez D
Ned Tijdschr Geneeskd; 1990 Dec; 134(52):2524-9. PubMed ID: 2270127
[No Abstract] [Full Text] [Related]
56. [Computer tomography (CT) in the choice of treatment and the planning of percutaneous transhepatic biliary drainage in obstructive jaundice due to tumour (author's transl)].
Luska G; Elgeti H; Wanner K; Rumpf KD; Gerber R
Rofo; 1981 Jan; 134(1):28-34. PubMed ID: 6452330
[TBL] [Abstract][Full Text] [Related]
57. A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma.
Taggar AS; Mann P; Folkert MR; Aliakbari S; Myrehaug SD; Dawson LA
Radiother Oncol; 2021 Dec; 165():60-74. PubMed ID: 34695521
[TBL] [Abstract][Full Text] [Related]
58. Malignant biliary obstruction: intracavitary treatment with a high-dose-rate remote afterloading device.
Haffty BG; Mate TP; Greenwood LH; Peschel RE; Weissberg JB
Radiology; 1987 Aug; 164(2):574-6. PubMed ID: 3602405
[TBL] [Abstract][Full Text] [Related]
59. [Percutaneous transluminal irradiation of biliary tract cancer using iridium].
Luska G; Junker D; Lehr L; Rieder P
Rofo; 1986 Jun; 144(6):722-7. PubMed ID: 3012710
[TBL] [Abstract][Full Text] [Related]
60. [Endoprosthesis in the bile ducts. Palliative treatment of malignant stenosing processes in the bile ducts].
Kolmannskog F; Bergan A
Tidsskr Nor Laegeforen; 1981 Jan; 101(1B):97-100. PubMed ID: 6161426
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
